Project Manager – HIV Viral Suppression Adherence Toolkit, Centers for Disease Control and Prevention (CDC)

Project Manager – HIV Viral Suppression Adherence Toolkit, Centers for Disease Control and Prevention (CDC)

In the era of tenofovir-lamivudine-dolutegravir (TLD), an extremely effective anti-retroviral therapy, individuals living with HIV who do not achieve viral load suppression require personalized, intensive attention to prevent progression of HIV and help overcome barriers to adherence.  However, there are few studies regarding evidence based practices for promoting adherence in this setting.  The goal is to identify the best evidence based practices for promoting ART adherence and share these in an efficient, effective way with our partners in PEPFAR supported countries.

Find more details and instructions for applying in the job posting on 12Twenty. Application deadline is September 16th at 11:59pm!


Log out of this account

Leave a Reply

Upcoming Events

  • EGDRC Seminar: Lynn Aboue-Jaoudé January 14, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/Lynn-Abou-JaoudeEvent Type: Seminar SeriesSeries: Health System Users in Vulnerable Situations: Normative Experiences and “New Ways of Life”Speaker: Lynn Abou-JaoudéContact Name: Wendy GillContact Email: wggill@emory.eduLink: https://tinyurl.com/Lynn-Abou-JaoudeDr. Lynn Abou-Jaoudé studies sociocultural challenges in healthcare experiences, focusing on qualitative research and diabetes prevention at the University of Lille’s LUMEN lab.
  • GCDTR Seminar: Erin Ferranti, PhD, MPH, RN January 21, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/ErinFerrantiEvent Type: Seminar SeriesSeries: Cardiometabolic Risk and Resource Connection in Maternal HealthSpeaker: Erin Ferranti, PhD, MPH, RNContact Name: Wendy GillContact Email: wggill@emory.eduRoom Location: RRR_R809Link: https://tinyurl.com/ErinFerrantiDr. Erin Ferranti, Emory Assistant Professor, researches women’s cardiometabolic disease prevention, health inequities, maternal morbidity, farmworker health, diabetes, and hypertension using biomarkers for early risk identification.

Follow Us on Social Media: